Clinical Trial Update: Efficacy and Safety of Famitinib Versus Sunitinib in the Treatment of Advanced Gastrointestinal Stromal Tumour Patients After Failure of Imatinib [Phase 3]

View source ↗

Summary

Phase 3 trial comparing famitinib to sunitinib in advanced GIST after imatinib failure; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumors

Drugs mentioned

• Famitinib (Famitinib)
• Sunitinib (sunitinib)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Gastrointestinal Stromal Tumors | Phase 3 | Status: TERMINATED